Cytokinetics Inc vs TeraWulf Inc — how do they compare? Cytokinetics Inc trades at $76.75 (market cap $10.63B), while TeraWulf Inc trades at $17.39 (market cap $8.35B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | WULF | |
|---|---|---|
Market Cap | $10.63B | $8.35B |
Sector | Technology | Technology |
52-Week High | $87.26 | $28.98 |
52-Week Low | $34.31 | $5.24 |
Enterprise Value | $10.74B | $10.97B |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →